Abstract
Letter to the editor for the article"efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study".
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have